期刊文献+

siRNA表达框架对TNF-α和IL-1的特异性抑制

siRNA expression cassettes specifically inhibit excretion of TNF-α and IL-1 in mice macrophages
暂未订购
导出
摘要 [目的]利用siRNA表达框架研究RNA干扰技术对小鼠腹腔活化巨噬细胞分泌TNF-α和IL-1的抑制作用及其干扰序列的特异性。[方法]原代培养小鼠腹腔巨噬细胞,构建针对小鼠TNF-α和IL-1的siRNA表达框架,转染细胞,用ELISA方法检测TNF-α和IL-1分泌情况。[结果]TNF-α干扰组TNF-α分泌量(21.87±1.20)pg/mL较IL-1干扰组(28.02±1.03)pg/mL及对照组(27.64±1.92)pg/mL均明显降低,差异有显著性意义(P<0.05)。IL-1干扰组IL-1分泌量(40.37±4.02)pg/mL较TNF-α干扰组(57.86±3.91)pg/mL及对照组(59.55±3.57)pg/mL均明显降低,差异有显著性意义(P<0.05)。[结论]构建的针对TNF-α和IL-1的siRNA表达框架能够明显抑制巨噬细胞分泌TNF-α和IL-1,且干扰作用具有序列特异性。 [ Objective] To study the specifical effect of RNA interference to inhibit the excretion of TNF- α and IL- 1 in mice activated peritoneal macrophages with siRNA expression cassettes. [ Methods ] Stimulate the primary culture of peritoneal macrophages with LPS. Prepare siRNA expression cassettes that target TNF - α and IL - 1, then transfect them to macrophages. Collect the cell culture upper liquid to assay the concentration of TNF - α and IL - 1 α with ELISA. [ Resuits ] The concentration of TNF - α of cell culture upper liquid in TNF - α interference group( 21.87 ± 1.20 ) pg/mL is ob- viously lower than that in IL - 1 interference group( 28.02 ± 1.03 ) pg/mL ( P 〈 0. 05 ) and that in negative - control group (27.64 ± 1.92) pg/mL ( P 〈 0. 05 ). The concentration of IL - 1 of cell culture upper liquid in IL - 1 interference group (40.37 ± 4.02 ) pg/mL is obviously lower than that in TNF - α interference group( 57.86 ± 3.91 ) pg/mL ( P 〈 0. 05 ) and that in negative - control group( 59.55 ± 3.57 ) pg/mL ( P 〈 0.05 ). [ Conclusion ] siRNA expression cassettes that aim TNF - α and IL - 1 target genes produce specific interference effect in inhibitory excretion of TNF - α and IL - 1 in mice macrophages.
出处 《大连医科大学学报》 CAS 2008年第6期527-529,共3页 Journal of Dalian Medical University
关键词 RNA干扰 siRNA表达框架 肿瘤坏死因子Α 白细胞介素-1 RNA interference siRNA expression cassettes post -transcriptional gene silencing tumor necrosis factor al- pha interleukin - 1
  • 相关文献

参考文献9

  • 1Wang S, Shi Z, Liu W, et al. Deveiopment and validation of vectors containing multiple siRNA expression cassettes for maximizing the efficiency of gene silencing [ J ]. BMC Biotechnol,2006,22 : 6 - 15.
  • 2Popa C, Netea MG, Van Riel PL. The role of TNF - alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk [ J ]. J Lipid Res, 2007,48 ( 4 ) : 751 - 762.
  • 3Gordon S. The macrophage: past, present and future [ J ]. Eur J Immunol,2007,37:9 - 17.
  • 4Bradley JR. TNF - mediated inflammatory disease [ J ]. J Pathol,2008,214 (2) : 149 - 160.
  • 5Holmgren C, Esplin MS, Hamblin S, et al. Evaluation of the use of anti - TNF - alpha in an LPS - induced murine model [J]. J Reprod Immunol,2008,78 (2) : 134 - 139.
  • 6Kpvarik P, Sauer I, Schaljo B. Molecular mechanisms of the anti-inflammatory function of interferons [ J ]. Immunobiology,2007 ,212 :895 -901.
  • 7Hannon GJ. RNA interference [ J ]. Nature, 2002,418 : 244 -251.
  • 8Jun Yuan A, Chary1 M, Dutton B, et al. RNAi mediated MMP - 1 silencing inhibits human chondrosarcoma invasion [ J ]. J Orthop Res ,2005 ,23 : 1467 - 1474.
  • 9Renu Wadhwaa, Sunil C Kaula, Zaman MA, et al. Know - how of RNA interference and its applicationsin research and therapy[ J]. Mutat Res,2004 ,567 :71 - 84.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部